These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 7794746)

  • 21. Minimally differentiated acute myeloid leukaemia (AML-M0): cytochemical, immunophenotypic and cytogenetic analysis of 19 cases.
    Venditti A; Del Poeta G; Stasi R; Masi M; Bruno A; Buccisano F; Cox C; Coppetelli U; Aronica G; Simone MD
    Br J Haematol; 1994 Dec; 88(4):784-93. PubMed ID: 7819103
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Incidence and significance of cryptic chromosome aberrations detected by fluorescence in situ hybridization in acute myeloid leukemia with normal karyotype.
    Cuneo A; Bigoni R; Cavazzini F; Bardi A; Roberti MG; Agostini P; Tammiso E; Ciccone N; Mancini M; Nanni M; De Cuia R; Divona M; La Starza R; Crescenzi B; Testoni N; Rege Cambrin G; Mecucci C; Lo Coco F; Saglio G; Castoldi G
    Leukemia; 2002 Sep; 16(9):1745-51. PubMed ID: 12200689
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CD19-positive acute myeloblastic leukemia with trisomy 21 as a sole acquired karyotypic abnormality.
    Wang HF; Cheng YZ; Wang HP; Chen ZM; Lou JY; Jin J
    J Zhejiang Univ Sci B; 2009 Nov; 10(11):833-8. PubMed ID: 19882758
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transformation of myelodysplastic syndromes into acute myeloid leukemias.
    Shi J; Shao ZH; Liu H; Bai J; Cao YR; He GS; Tu MF; Wang XL; Hao YS; Yang TY; Yang CL
    Chin Med J (Engl); 2004 Jul; 117(7):963-7. PubMed ID: 15265365
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Correlation of cytogenetic results with immunophenotype, genotype, clinical features, and ras mutation in acute myeloid leukemia. A study of 235 Chinese patients in Taiwan.
    Tien HF; Wang CH; Lin MT; Lee FY; Liu MC; Chuang SM; Chen YC; Shen MC; Lin KH; Lin DT
    Cancer Genet Cytogenet; 1995 Oct; 84(1):60-8. PubMed ID: 7497445
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunologic characteristics and prognosis of myelodysplastic syndrome new subtype: refractory anemia with excess blasts-II.
    Wei J; Zhou XF; Zhao F; Zhou JF; Chen Y
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Feb; 17(1):111-6. PubMed ID: 19236759
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Trisomy 10 and acute myeloid leukemia.
    Czepulkowski B; Powell AR; Pagliuca A; Mufti GJ
    Cancer Genet Cytogenet; 2002 Apr; 134(1):81-3. PubMed ID: 11996802
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association between trisomy 8 and the immunophenotype of blast cells from acute leukemias secondary to a myelodysplastic syndrome or chronic myeloproliferative disorders.
    Garcia-Isidoro M; Tabernero MD; Najera ML; Lopez-Berges MC; Martinez A; Durán A; Garcia JL; Hernandez JM; Garcia Marcos MA; San Miguel JF; Orfao A
    Ann Hematol; 1997 May; 74(5):209-14. PubMed ID: 9200992
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Trisomy 21 as the sole acquired karyotypic abnormality in an adult patient with CD7-positive acute myeloid leukemia.
    Kondo H; Kobayashi A; Iwasaki H
    Cancer Genet Cytogenet; 2001 May; 127(1):77-9. PubMed ID: 11408071
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterization of a recurrent translocation t(2;3)(p15-22;q26) occurring in acute myeloid leukaemia.
    Trubia M; Albano F; Cavazzini F; Cambrin GR; Quarta G; Fabbiano F; Ciambelli F; Magro D; Hernandezo JM; Mancini M; Diverio D; Pelicci PG; Coco FL; Mecucci C; Specchia G; Rocchi M; Liso V; Castoldi G; Cuneo A
    Leukemia; 2006 Jan; 20(1):48-54. PubMed ID: 16619048
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The immunophenotypic and clinical characteristics of NPM1 mutated acute myeloid leukemia patients].
    Liu YR; Chang Y; Ruan GR; Qin YZ; Lai YY; Shi HX; Wang YZ; Li LD; Jiang B; Li JL
    Zhonghua Xue Ye Xue Za Zhi; 2013 Feb; 34(2):98-103. PubMed ID: 23611213
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Clinical and experimental studies of childhood acute myeloid leukemia with 11q23/MLL rearrangements].
    He YX; Xue YQ; Wang HY; Shao XJ; Pan JL; Xu J; Yang NC; Ji ZH; Huang YP; Hu SY
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2012 Dec; 29(6):677-82. PubMed ID: 23225048
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Therapy-related acute myeloid leukemia/myelodysplasia with balanced 21q22 translocations.
    Arber DA; Slovak ML; Popplewell L; Bedell V; Ikle D; Rowley JD;
    Am J Clin Pathol; 2002 Feb; 117(2):306-13. PubMed ID: 11863228
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Trisomy 4 as the sole karyotypic anomaly in acute biphenotypic leukemia with B lineage markers and in acute minimally differentiated myeloid leukemia (M0).
    Cox-Froncillo MC; Zollino M; Del Poeta G; Bajer J; Stasi R; Venditti A; Tribalto M; Neri G; Papa G
    Cancer Genet Cytogenet; 1995 Mar; 80(1):66-7. PubMed ID: 7697636
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic impact of karyotype and immunologic phenotype in 125 adult patients with de novo AML.
    Marosi C; Köller U; Koller-Weber E; Schwarzinger I; Schneider B; Jäger U; Vahls P; Nowotny H; Pirc-Danoewinata H; Steger G
    Cancer Genet Cytogenet; 1992 Jul; 61(1):14-25. PubMed ID: 1638477
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Significance of trilineage myelodysplasia in de novo acute myeloid leukaemia during remission rather than at diagnosis.
    Tamura S; Takemoto Y; Wada H; Itoh T; Mori A; Saheki K; Okada M; Takatsuka H; Fujimori Y; Okamoto T; Kakishita E
    Br J Haematol; 1998 Jun; 101(4):743-8. PubMed ID: 9674749
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Trisomy 13 and myeloid malignancy--characteristic blast cell morphology: a United Kingdom Cancer Cytogenetics Group survey.
    Mehta AB; Bain BJ; Fitchett M; Shah S; Secker-Walker LM
    Br J Haematol; 1998 Jun; 101(4):749-52. PubMed ID: 9674750
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Minimally differentiated acute myeloid leukemia (AML M0): clinico-biological findings of 29 cases.
    Cascavilla N; Melillo L; D'Arena G; Greco MM; Carella AM; Sajeva MR; Perla G; Matera R; Minervini MM; Carotenuto M
    Leuk Lymphoma; 2000 Mar; 37(1-2):105-13. PubMed ID: 10721774
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cytogenetic profile of minimally differentiated (FAB M0) acute myeloid leukemia: correlation with clinicobiologic findings.
    Cuneo A; Ferrant A; Michaux JL; Boogaerts M; Demuynck H; Van Orshoven A; Criel A; Stul M; Dal Cin P; Hernandez J
    Blood; 1995 Jun; 85(12):3688-94. PubMed ID: 7780152
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical characteristics of patients with de novo acute myeloid leukaemia and isolated trisomy 11: a Cancer and Leukemia Group B study.
    Heinonen K; Mrózek K; Lawrence D; Arthur DC; Pettenati MJ; Stamberg J; Qumsiyeh MB; Verma RS; MacCallum J; Schiffer CA; Bloomfield CD
    Br J Haematol; 1998 Jun; 101(3):513-20. PubMed ID: 9633896
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.